Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference

July 30, 2024
PDF Version

BRANFORD, Conn.--(BUSINESS WIRE)--Jul. 30, 2024-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Canaccord Genuity 44th Annual Growth Conference taking place in Boston August 13-15, 2024.

Jeff Hawkins, Quantum-Si's Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will participate in a fireside chat on Tuesday, August 13th, at 11:00 AM ET.

A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.

Investor Contact
Doug Farrell, VP, Investor Relations
ir@quantum-si.com

Media Contact
Katherine Atkinson, SVP of Commercial Marketing
media@quantum-si.com

Source: Quantum-Si Incorporated